Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Interest & Investment Income: 2019-2025

Historic Interest & Investment Income for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to $3.3 million.

  • Benitec Biopharma's Interest & Investment Income rose 12.61% to $1.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.3 million, marking a year-over-year increase of 263.50%. This contributed to the annual value of $3.3 million for FY2025, which is 263.50% up from last year.
  • As of FY2025, Benitec Biopharma's Interest & Investment Income stood at $3.3 million, which was up 263.50% from $904,000 recorded in FY2024.
  • Over the past 5 years, Benitec Biopharma's Interest & Investment Income peaked at $3.3 million during FY2025, and registered a low of -$33,000 during FY2023.
  • In the last 3 years, Benitec Biopharma's Interest & Investment Income had a median value of $904,000 in 2024 and averaged $1.4 million.
  • Per our database at Business Quant, Benitec Biopharma's Interest & Investment Income slumped by 433.33% in 2022 and then spiked by 2,839.39% in 2024.
  • Yearly analysis of 5 years shows Benitec Biopharma's Interest & Investment Income stood at -$6,000 in 2021, then crashed by 433.33% to -$32,000 in 2022, then declined by 3.12% to -$33,000 in 2023, then surged by 2,839.39% to $904,000 in 2024, then spiked by 263.50% to $3.3 million in 2025.